<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED PURSUANT TO 13d-2(b)
(Amendment No. __)*
NOVAMED EYECARE, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
66986W 10 8
- --------------------------------------------------------------------------------
(CUSIP Number)
December 31, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
________________
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 13
<PAGE>
SCHEDULE 13G
CUSIP No. 66986W 10 8 Page 2 of 13 Pages
- --------------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
DOUGLAS WILLIAMS FAMILY LIMITED PARTNERSHIP
- --------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- --------------------------------------------------------------------------------
SEC USE ONLY
3
- --------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
GEORGIA
- --------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 1,679,488
SHARES -------------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
-0-
OWNED BY
-------------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 1,679,488
PERSON -------------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
-0-
- --------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
1,679,488
- --------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- --------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
7.0%
- --------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13G
- --------------------- ------------------
CUSIP NO. 66986W 10 8 Page 3 of 13 Pages
- --------------------- ------------------
- --------------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
BRODERSEN-WILLIAMS EYE INSTITUTE, P.C.
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
INDIANA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 1,679,488
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
-0-
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 1,679,488
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
-0-
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
1,679,488
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
7.0%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
CO
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13G
- --------------------- ------------------
CUSIP NO. 66986W 10 8 Page 4 of 13 Pages
- --------------------- ------------------
- --------------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
DOUGLAS P. WILLIAMS, M.D.
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
U.S.A.
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 1,747,488
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
-0-
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 1,747,488
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
-0-
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
1,747,488
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
7.3%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- --------------------- ------------------
CUSIP No. 66986W 10 8 Page 5 of 13 Pages
- --------------------- ------------------
Item 1(a) Name of Issuer:
NovaMed Eyecare, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
980 North Michigan Avenue
Chicago, Illinois 60611
Item 2(a) Name of Person Filing:
Douglas Williams Family Limited Partnership
Brodersen-Williams Eye Institute, P.C.
Douglas P. Williams, M.D.
Item 2(b) Address of Principal Business Office or, if None, Residence:
Douglas Williams Family Limited Partnership
6850 Hohman Avenue
Hammond, Indiana 46324
Brodersen-Williams Eye Institute, P.C.
6850 Hohman Avenue
Hammond, Indiana 46324
Douglas P. Williams, M.D.
6850 Hohman Avenue
Hammond, Indiana 46324
Item 2(c) Citizenship:
Douglas Williams Family Limited Partnership: Georgia
Brodersen-Williams Eye Institute, P.C.: Indiana
Douglas P. Williams, M.D.: U.S.A.
Item 2(d) Title of Class of Securities:
Common Stock, par value $.01 per share
Item 2(e) CUSIP Number:
66986W 10 8
<PAGE>
- ----------------- ------------------
CUSIP 66986W 10 8 Page 6 of 13 Pages
- ----------------- ------------------
Item 3. If this Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b)
or (c), Check Whether the Person Filing is a:
Not Applicable.
Item 4. Ownership:
(a) Amount Beneficially Owned:
Douglas Williams Family Limited Partnership: 1,679,488
Brodersen-Williams Eye Institute, P.C.: 1,679,488/(1)/
Douglas P. Williams, M.D.: 1,747,488/(2)/
(b) Percent of Class:
Douglas Williams Family Limited Partnership: 7.0%
Brodersen-Williams Eye Institute, P.C.: 7.0%/(1)/
Douglas P. Williams, M.D.: 7.3%/(2)/
(c) Number of shares as to which such person has:
Douglas Williams Family Limited Partnership:
(i) sole power to vote or to direct the vote: 1,679,488
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition
of: 1,679,488
(iv) shared power to dispose or to direct the disposition
of: -0-
<PAGE>
- --------------------- ------------------
CUSIP No. 66986W 10 8 Page 7 of 13 Pages
- --------------------- ------------------
Brodersen-Williams Eye Institute, P.C.:
(i) sole power to vote or to direct the vote: 1,679,488
/(1)/
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition
of: 1,679,488/(1)/
(iv) shared power to dispose or to direct the disposition
of: -0-
Douglas P. Williams, M.D.:
(i) sole power to vote or to direct the vote: 1,747,488
/(2)/
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition
of: 1,747,488/(2)/
(iv) shared power to dispose or to direct the disposition
of: -0-
Item 5. Ownership of Five Percent or less of a Class:
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable.
________________
/(1)/Brodersen-Williams Eye Institute, P.C. ("BWPC") is the general partner of
Douglas Williams Family Partnership ("DWFP"). In such capacity, BWPC has
sole voting and investment power with respect to the shares held by DWFP
and, therefore, may be deemed to be the beneficial owner of the shares
directly owned by DWFP.
/(2)/Dr. Williams holds 68,000 shares individually and is the President, sole
Director and sole shareholder of BWPC. In such capacity, Dr. Williams may
be deemed to be the beneficial owner of the shares directly owned by DWFP.
<PAGE>
- --------------------- ------------------
CUSIP No. 66986W 10 8 Page 8 of 13 Pages
- --------------------- ------------------
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company:
Not Applicable.
Item 8. Identification and Classification of Members of the Group:
Not Applicable.
Item 9. Notice of Dissolution of Group:
Not Applicable.
Item 10. Certification:
Not Applicable.
<PAGE>
- --------------------- ------------------
CUSIP No. 66986W 10 8 Page 9 of 13 Pages
- --------------------- ------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 11, 2000
DOUGLAS WILLIAMS FAMILY LIMITED PARTNERSHIP
By: Brodersen-Williams Eye Institute, P.C.,
its General Partner
By: /s/ DOUGLAS P. WILLIAMS, M.D.
-----------------------------
Its: President
<PAGE>
- --------------------- -------------------
CUSIP No. 66986W 10 8 Page 10 of 13 Pages
- --------------------- -------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 11, 2000
BRODERSEN-WILLIAMS EYE INSTITUTE, P.C.
By: /s/ DOUGLAS P. WILLIAMS, M.D.
-----------------------------
Its: President
<PAGE>
- --------------------- -------------------
CUSIP No. 66986W 10 8 Page 11 of 13 Pages
- --------------------- -------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 11, 2000
/s/ DOUGLAS P. WILLIAMS, M.D.
-----------------------------
Douglas P. Williams, M.D.
<PAGE>
- --------------------- -------------------
CUSIP No. 66986W 10 8 Page 12 of 13 Pages
- --------------------- -------------------
Exhibit Index
-------------
Page No.
--------
1. Joint Filing Agreement dated February 11, 2000
by and between Douglas Williams Family Limited
Partnership, Brodersen-Williams Eye Institute,
P.C., and Douglas P. Williams, M.D. 13
<PAGE>
CUSIP No. 66986W 10 8 Page 13 of 13 Pages
EXHIBIT 1
JOINT FILING
------------
Douglas Williams Family Limited Partnership, Brodersen-Williams Eye
Institute, P.C. and Douglas P. Williams, M.D. hereby agree that the Schedule 13G
to which this Agreement is attached is being filed on behalf of each of Douglas
Williams Family Limited Partnership, Brodersen-Williams Eye Institute, P.C. and
Douglas P. Williams, M.D.
Date: February 11, 2000
DOUGLAS WILLIAMS FAMILY LIMITED PARTNERSHIP
By: Brodersen-Williams Eye Institute, P.C.,
its General Partner
By: /s/ DOUGLAS P. WILLIAMS, M.D.
-----------------------------
Its: President
BRODERSEN-WILLIAMS EYE INSTITUTE, P.C.
By: /s/ DOUGLAS P. WILLIAMS, M.D.
-----------------------------
Its: President
/s/ DOUGLAS P. WILLIAMS, M.D.
-----------------------------
Douglas P. Williams, M.D.
